Publications

Click to view the corresponding publications:

1995–1999

1999

• Abrams DB, Clark MM, King T. Increasing the impact of nicotine dependence treatment: conceptual and practical considerations in a stepped-care plus treatment-matching approach. In J.A. Tucker, M. Donovan, and G.A. Marlatt (Eds.). Changing Addictive Behavior: Bridging Clinical and Public Health Strategies. The Guilford Press, NY, NY: Pages 307-330.
• Hayford KE, Patten CA, Rummans TA, Schroeder DR, Offord KP, Croghan IT, Glover ED, Sachs DPL, Hurt RD. Efficacy of bupropion for smoking cessation in smokers with former history of major depression or alcoholism. Br J Psychol. 174:173-178, 1999.
• Hays JT, Croghan IT, Schroeder DR, Offord KP, Hurt RD, Wolter TD, Nides MA, Davidson M. Over-the-counter (OTC) transdermal nicotine patch therapy. Am J Public Health. 89 (11):1701-1707, 1999.
• Hays JT, Schroeder DR, Offord KP, Croghan IT, Patten CA, Hurt RD, Jorenby DE, Fiore MC. Response to nicotine dependence treatment in smokers with current and past alcohol problems. Ann Behav Med. 21(3):244-250, 1999.
• Hughes JR, Goldstein MG, Hurt RD, Shiffman S. Recent advances in the pharmacotherapy of smoking. JAMA. 281(1):72-76, 1999.
• Hurt R. The influence of the Minnesota Tobacco Trial on the healthcare community and tobacco regulation. William Mitchell Law Review. 25(2):455-469, 1999.
• Hurt, RD. New medications for nicotine dependence treatment. Nicotine Tob Res. 1:s175-S179, 1999.
• Hurt RD. Treat tobacco dependence and "bend the trend" (editorial). Bull World Health Org. 77(5):367, 1999.
• Ji A, Lawson GM, Anderson R, Dale LC, Croghan IT, Hurt RD. A new gas chromatography-mass spectrometry method for simultaneous determination of total and free trans-3’-hydroxycotinine and cotinine in the urine of subjects receiving transdermal nicotine. Clin Chem. 45(1):85-91, 1999.
• Ogburn PL, Hurt RD, Croghan IT, Schroeder DR Ramin KD, Offord KP, Moyer TP. Nicotine patch use in pregnant smokers – nicotine and cotinine levels and fetal effects. Am J Obstet Gynecol. 181:736-43, 1999.
• Patten CA, Rummans TA, Croghan IT, Hurt RD, Hays JT. Development of depression during placebo-controlled trials of bupropion for smoking cessation: case reports. J Clinical Psychology. 60:436-441, 1999.
• Pinto BM, Borrelli B, King TK, Bock BC, Clark MM, Roberts M, Marcus BH. Weight control smoking among sedentary women. Addict Behav. 24(1):75-86, 1999.
• Wong GY, Wolter TD, Croghan GA, Croghan IT, Offord KP, Hurt RD. A randomized trial of naltrexone for smoking cessation. Addiction. 94(8):1227-1237, 1999.

Back to Top

1998

• Baskin LB, Anderson RW, Charlson JR, Hurt RD, Lawson GM. A solid phase extraction method for determination of nicotine in serum by isotope dilution gas chromatography/mass spectrometry with selected ion monitoring. Ann Clin Biochem. 35:522-527, 1998.
• Croghan IT, Offord KP, Patten CP, Hurt RD. Cost-effectiveness of AHCPR Guidelines for smoking. Letter to the Editor, JAMA. 279:836-837, 1998.
• Dale LC, Schroeder DR, Wolter T, Croghan IT, Hurt RD, Offord KP. Weight change after smoking cessation using variable doses of transdermal nicotine replacement. J Gen Intern Med. 13:9-15, 1998.
• Dale LC, Hurt RD, Hays JT. Drug therapy to aid in smoking cessation: tips on maximizing patients; chances for success. Postgrad Med. 104(6):75-84, 1998.
• Eberman K. How to help your partner quit smoking. Vitality’s Drug-Free 39: A. 1998.
• Eberman KM, Patten CA, Dale LC. Counseling patients to quit smoking: what to say, when to say it, and how to use your time to advantage. Postgrad Med. 104(6):89-94, 1998.
• Hays JT, Dale LC, Hurt RD, Croghan IT. Trends in smoking-related diseases: Why smoking cessation is still the best medicine. Postgrad Med. 104(6):56-71, 1998.
• Hays JT, Hurt RD. Tobacco legislation: time to right some wrongs. Guest editorial. Postgrad Med. 104(6):11-12, 1998.
• Hooten WM, Bruns HK, Hays JT. Inpatient treatment of severe nicotine dependence in a patient with thromboangiitis obliterans (Buerger’s disease). Mayo Clin Proc. 73:529-532, 1998.
• Hurt RD, Eberman KM, Slade J, Karan L. Treating nicotine addiction in patients with other addictive disorders. Management. 1998.
• Hurt RD, Dale LC, Croghan GA, Croghan IT, Gomez-Dahl L, Offord KP. Nicotine nasal spray for smoking cessation: pattern of use, side effects, relief of withdrawal symptoms, and cotinine levels. Mayo Clin Proc. 73:118-125, 1998.
• Hurt RD, Robertson CR. Prying open the door to the tobacco industry’s secrets about nicotine. JAMA. 280 (13):1173-1181, 1998.
• Hurt RD, Offord KP, Croghan IT, Croghan GA, Gomez-Dahl LC, Wolter TD, Dale LC, Moyer TP. Temporal effects of nicotine nasal spray and gum on nicotine withdrawal symptoms. Psychopharmacology. 140:98-104, 1998.
• Hurt RD, Sachs DPL, Glover ED. Sustained-release bupropion for smoking cessation – reply. Letter to the editor. N Engl J Med. 338:620, 1998.
• Lawson GM, Hurt RD, Dale LC, Offord KP, Croghan IT, Schroeder DR, Jiang N. Application of urine nicotine and cotinine excretion rates to assessment of nicotine replacement in light, moderate, and heavy smokers undergoing transdermal therapy. J Clin Pharmacol. 38(6):510-516, 1998.
• Lawson GM, Hurt RD, Dale LC, Offord KP, Croghan IT, Schroeder DR, Jiang N. Application serum nicotine and plasma cotinine concentrations to assess nicotine replacement in light, moderate, and heavy smokers undergoing transdermal therapy. J Clin Pharmacol. 38(6):502-509, 1998.
• McPhail I, Hurt RD, Miller VM. Mechanism of cardiovascular effects of nicotine. Curr Top Pharmacol. 4:265-280,1998.
• Miller VM, Lewis DA, Rud KS, Offord KP, Croghan IT, Hurt RD. Plasam nitric oxide before and after smoking cessation with nicotine nasal spray. J Clin Pharmacol. 38:22-27, 1998.
• Schubiner H, Herrold A, Hurt RD. Tobacco cessation and youth: the feasibility of brief office interventions for adolescents. Prev Med. 27:A47-A54, 1998.

Back to Top

1997

• Compton RF, Sandborn WJ, Lawson GM, Sheets AJ, Mays DC, Zins BJ, Tremaine WJ, Lipsky JJ, Mahoney DW, Zinsmeister AR, Offord KP, Hurt RD, Evans BK, Green J. A dose-ranging pharmacokinetic study of nicotine tartrate following single-dose delayed-release oral and intravenous administration. Aliment Pharmacol Ther. 11:865-874, 1997.
• Croghan IT, Offord KP, Evans RW, Schmidt S, Gomez-Dahl L, Schroeder DR, Patten CA, Hurt RD. Cost-effectiveness of treating nicotine dependence: The Mayo Clinic experience. Mayo Clin Proc. 72:917-924, 1997.
• Dale LC, Olsen DA, Patten CA, Schroeder DR, Croghan IT, Hurt RD, Offord KP, Wolter TD. Predictors of smoking cessation among elderly smokers treated for nicotine dependence. Tob Control. 6:181-187, 1997.
• Hurt RD. Comments on Perkins’s "Membership of tobacco industry scientists in scientific societies." Commentaries. Addiction. 92(5):521-529, 1997.
• Hurt RD, Sachs DP, Glover ED, Offord KP, Johnston JA, Dale LC, Khayrallah MA, Schroeder DR, Glover PN, Sullivan CR, Croghan IT, Sullivan PM. A comparison of sustained release bupropion and placebo for smoking cessation. New Engl J Med. 337:1195-1202, 1997.
• Hurt RD, Kottke TE. Magazines containing tobacco advertisements: Proscription not subscription. JAMA. 278:117, 1997.
• Sandborn WJ, Tremain WJ, Leighton JA, Lawson GM, Zins BJ, Compton RF, Mays DC, Lipsky JJ, Batts KP, Offord KP, Hurt RD, Green J. Nicotine tartrate liquid enemas for mildly to moderately active left-sided ulcerative colitis unresponsive to first-line therapy: A pilot study. Aliment Pharmacol Ther. 11:663-671, 1997.
• Sandborn WJ, Tremaine WJ, Offord KP, Lawson GM, Peterson BT, Batts KP, Croghan IT, Dale LC, Schroeder DR, Hurt RD. Transdermal nicotine for mildly to moderately active ulcerative colitis. A randomized, double-blind, placebo controlled trial. Ann Intern Med. 126:364-371, 1997.
• Zins BJ, Sandborn WJ, Mays DC, Lawson GM, McKinney JA, Tremaine WJ, Mahoney DW, Zinsmeister AR, Hurt RD, Offord KP, Lipsky JJ. Pharmacokinetics of nicotine tartrate after single-dose liquid enema, oral and intravenous administration. J Clin Pharmacol. 37(5):426-436, 1997.

Back to Top

1996

• Clark MM, Niaura R, King RK, Pera V. Depression, smoking, activity level and health status: pretreatment predictors of attrition in obesity treatment. Addict Behav. 21(4):509-513, 1996.
• Fagerström KO, Kunze M, Schoberberger R, Breslau N, Hughes JR, Hurt RD, Puska P, Ramström L, Zatonski W. Nicotine dependence versus smoking prevalence: comparisons among countries and categories of smokers. Tob Control. 5:52-56, 1996.
• Guise BJ, Goldstein MG, Clark MM, Therbarge, RW. Behavior change: The example of smoking cessation. In: Noble J, Greene HL, Levinson W, Modest GA, Young MJ (eds) Textbook in Primary Care Medicine. 2nd Edition. St. Louis, Missouri: Mosby-Year Book, Inc., Chap. 24, p. 1650-1656, 1996.
• Hays JT, Hurt RD, Dale RD. Smoking cessation and prevention of coronary heart disease and myocardial infarction. In: Manson JE, Ridker PM, Gaziano JM, Hennekens CH, (eds) Prevention of Myocardial Infarction. New York: Oxford University Press, Chap. 5, p. 99-129, 1996.
• Hurt RD, Offord KP, Croghan IT, Gomez-Dahl L, Kottke TE, Morse RM, Melton III LJ. Mortality following inpatient addictions treatment: role of tobacco use in a community-based cohort. JAMA. 274(14):1097-1103, 1996.
• Hurt RD. Smoking cessation in primary care. Indiana Med. 89(2):165-168, 1996.
• Patten CA, Bruce BK, Hurt RD, Offord KP, Allison TG, Clemensen LR, Gau GT. Smoking cessation following a cardiac rehabilitation program. Journal of Prevention and Intervention in the Community. 13:161-176, 1996.
• Patten CA, Bruce BK, Hurt RD, Offord KP, Allison TG, Clemensen LR, Gau GT. Smoking cessation following a cardiac rehabilitation program. In: Piette JD, Kaplan RM, Ferrari JRT (eds) Preventing Illness Among People with Coronary Heart Disease. The Haworth Press, Inc. p. 161-176, 1996.
• Smith TA, House Jr RF, Croghan IT, Gauvin TR, Colligan RC, Offord KP, Gomez-Dahl LC, Hurt RD. Nicotine patch therapy in adolescent smokers. Pediatrics. 98(4):659-667, 1996.
• Wolter TD, Hauri PD, Schroeder DR, Wisbey JA, Croghan IT, Offord KP, Hurt RD. Effects of 24-hour nicotine replacement on sleep and daytime activity during smoking cessation. Prev Med. 25:601-610, 1996.

Back to Top

1995

• Dale LC, Hurt RD, Offord KP, Lawson GM, Croghan IT, Schroeder DR. High dose nicotine patch therapy: percent replacement and smoking cessation with placebo, 11, 22, and 44 mg/24 hour doses. JAMA. 274(17):1353-1358, 1995.
• Franke DL, Leistickow BN, Offord KP, Schmidt L, Hurt RD. Physician referrals for smoking cessation: outcome in those who show and don’t show. Prev Med. 24:194-200, 1995.
• Fredrickson PA, Hurt RD, Lee GM, Wingender L, Croghan IT, Lauger G, Gomez-Dahl LC, Offord KP. High dose transdermal nicotine therapy for heavy smokers: safety, tolerability and measurement of nicotine and cotinine levels. Psychopharmacology. 122:215-222, 1995.
• Hurt RD, Offord KP. Smoke-free medical center policies: a process in evolution. Tobacco and Health. Karen Slama, Ed. New York: Plenum Press, 1995. Pp. 491-494.
• Hurt RD. Smoking in Russia: what do Stalin and western tobacco companies have in common? Mayo Clin Proc. 70:1007-1011, 1995.
• Hurt RD, Croghan IT, Offord KP, Eberman KM, Morse RM. Attitudes toward nicotine dependence among chemical dependency unit staff - before and after a smoking cessation trial. J Subst Abuse Treat. 12(4):247-252, 1995.
• Hurt RD, Dale LC, Offord KP, Croghan IT, Hays JT, Gomez-Dahl LC. Nicotine patch therapy for smoking cessation in recovering alcoholics. Addiction. 90:1541-1546, 1995.
• Hurt RD, Offord KP, Lauger GG, Marusic Z, Fagerström K, Enright PL, Scanlon PD. Cessation of long-term nicotine gum use – a prospective, randomized trial. Addiction. 90:407-413, 1995.
• Jorenby DE, Smith SS, Hurt RD, Fiore MC, Offord KP, Croghan IT, Hays JT, Lewis SF, Baker TB. Varying the intensity of nicotine patch dose and smoking cessation counseling: does anything make a lasting difference? JAMA. 274:1347-1352, 1995.
• Kottke TE. Smoke-free 2000: a step closer. JAMA. (Editorial) 274:503-504, 1995.
• Kottke TE, Solberg, LI. Is it not time to make smoking a vital sign? Mayo Clin Proc. (Editorial) 70(3):303-304, 1995.
• Kottke TE, Solberg LI. Nicotine patches: a doubtful key to tobacco control? J Natl Cancer Inst. (Editorial) 87(2):71-72, 1995.
• Kottke TE, Solberg LI, Brekke ML. Tobacco use: prevention and control in HMOs. Health plans helping smokers. HMO Practice 9(3):128-133, 1995.
• Patten CA, Bruce BK, Hurt RD, Offord KP, Richardson JW, Clemens LR, Persons SM. Effects of a smoke-free policy on an inpatient psychiatric unit. Tob Control. 4:372-379, 1995.

Back to Top